Cargando…
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
An elevated low-density lipoprotein cholesterol concentration is a classical risk factor for cardiovascular disease. This has led to pharmacotherapy in patients with atherosclerotic heart disease or high heart disease risk with statins to reduce serum low-density lipoprotein cholesterol. Even in pat...
Autores principales: | Renee Ruhaak, L, van der Laarse, Arnoud, Cobbaert, Christa M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595551/ https://www.ncbi.nlm.nih.gov/pubmed/30889974 http://dx.doi.org/10.1177/0004563219827620 |
Ejemplares similares
-
Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019) -
Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
por: Bodde, Mathijs C., et al.
Publicado: (2018) -
Antithrombin diagnostics by mass spectrometry: Development and analytical validation of a next-generation test
por: Kruijt, Mirjam, et al.
Publicado: (2023) -
HILIC–MRM–MS
for Linkage-Specific Separation
of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen
Proteoforms
por: van der Burgt, Yuri E. M., et al.
Publicado: (2020) -
Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)